We are live on ! Find out more
ALBO

Albireo Pharma Inc
ALBO

Delisted

ALBO was delisted on the 2nd of March, 2023.

Back to rankings

69 hedge funds and large institutions have $270M invested in Albireo Pharma Inc in 2018 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 21 increasing their positions, 12 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

238% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 8

75% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 12

38% more funds holding

Funds holding: 50 → 69 (+19)

27% more capital invested

Capital invested by funds: $213M → $270M (+$56.6M)

Holders
69
Holders Change
+19
Holders Change %
+38%
% of All Funds
1.58%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
27
Increased
21
Reduced
12
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$14.5M
2
Federated Hermes
Federated Hermes
Pennsylvania
+$8.95M
3
State Street
State Street
Massachusetts
+$4.54M
4
ACH
ArrowMark Colorado Holdings
Colorado
+$3.49M
5
Northern Trust
Northern Trust
Illinois
+$2.72M

Top Sellers

Rank Fund Capital Flow
1
AWG
Alpha Wave Global
New York
-$5.7M
2
DZ Bank
DZ Bank
Germany
-$2.04M
3
TGHSA
TPG Group Holdings (SBS) Advisors
Texas
-$1.97M
4
Millennium Management
Millennium Management
New York
-$1.67M
5
AG
Artal Group
Luxembourg
-$1.55M
Name Holding Trade Value Shares
Change 		Change in
Stake
LCM
76
Laurion Capital Management
New York
– -$210K -6,438 Closed
1 2 3
4

ALBO Hedge Fund Activity: Q2 2018 in Review

69 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Albireo Pharma Inc (ALBO) for Q2 2018, worth a combined $270M — up 27% from $213M a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new ALBO positions and 8 closed out — a net gain of 19 holders — while 21 added to existing stakes and 12 trimmed.

The largest buyer was BlackRock, adding an estimated $14.5M. The largest seller was Alpha Wave Global, exiting entirely with an estimated $5.7M sold.

  • 69 institutional investors held Albireo Pharma Inc (ALBO) as of Q2 2018, up from 50 in Q1 2018.
  • Funds reported $270M of Albireo Pharma Inc stock for Q2 2018, up 27% quarter-over-quarter.
  • 27 funds opened new Albireo Pharma Inc positions in Q2 2018 and 8 closed out, a net change of +19 holders.
  • The largest Albireo Pharma Inc buyer in Q2 2018 was BlackRock, an estimated $14.5M added.
  • The largest Albireo Pharma Inc seller in Q2 2018 was Alpha Wave Global, an estimated $5.7M sold.

Based on aggregated 13F filings for Q2 2018.